{"id":1535,"date":"2024-09-12T15:22:40","date_gmt":"2024-09-12T13:22:40","guid":{"rendered":"https:\/\/hpbcrti.com\/liver-first-approach-strategy-in-liver-metastases-from-colorectal-cancer\/"},"modified":"2024-11-20T10:05:21","modified_gmt":"2024-11-20T09:05:21","slug":"liver-first-approach-strategy-in-liver-metastases-from-colorectal-cancer","status":"publish","type":"post","link":"https:\/\/hpbcrti.com\/en\/article\/liver-first-approach-strategy-in-liver-metastases-from-colorectal-cancer\/","title":{"rendered":"Long-term results of liver-first approach strategy in patients with advanced synchronous liver metastases from colorectal cancer."},"content":{"rendered":"<div class=\"w-full max-w-mw mx-auto px-16 lg:px-10_119 mw:px-153\">\n<p class=\"w-full max-w-900 font-satoshi font-medium text-16-20 lg:text-18-22 text-black mb-24\" >Eric Herrero, Mar\u00eda Galofr\u00e9, Alba Z\u00e1rate, Maribel Garc\u00eda-Domingo, Judith Camps, Fernando Pardo, Francisco Espin y Esteban Cugat.<\/p>\n<\/div><div class=\"w-full max-w-mw mx-auto px-16 lg:px-10_119 mw:px-153\">\n<p class=\"w-full max-w-900 font-satoshi font-medium text-16-20 lg:text-18-22 text-black mb-24\" ><\/p>\n<\/div><div class=\"w-full max-w-mw mx-auto px-16 lg:px-10_119 mw:px-153\">\n<p class=\"w-full max-w-900 font-satoshi font-medium text-16-20 lg:text-18-22 text-black mb-24\" >Retrospective descriptive analysis from a prospective database of hepatectomies from liver metastases (LM) from CRC in two centers. Between 2007-2019, 88 patients with CRC-ASLM (advanced synchronous liver metastases) were included in a LFA scheme. Bilobar (LM) was present in 65.9%, the mean number of lesions was 5.5 and mean size 42.7 mm. Response to treatment was assessed by RECIST criteria. Progression-free survival (PFS) and overall survival (OS) were estimated using Kaplan-Meier survival curves.<\/p>\n<\/div><div class=\"w-full max-w-mw mx-auto px-16 lg:px-10_119 mw:px-153\">\n<p class=\"w-full max-w-900 font-satoshi font-medium text-16-20 lg:text-18-22 text-black mb-24\" >In patients with CRC-ASLM the LFA allows control of the liver disease beforehand and an assessment of the tumor response to neoadjuvant chemotherapy, optimising the chance of potentially curative liver resection, which influences long-term survival.<\/p>\n<\/div><div class=\"w-full max-w-mw mx-auto px-16 lg:px-10_119 mw:px-153\">\n<p class=\"w-full max-w-900 font-satoshi font-medium text-16-20 lg:text-18-22 text-black mb-24\" ><a href=\"https:\/\/doi.org\/10.1016\/j.ciresp.2022.04.007\" target=\"_blank\" rel=\"noreferrer noopener\">Read the full article<\/a><\/p>\n<\/div>    <div class=\"module--image-gallery w-full h-full overflow-hidden\">\n      <div class=\"sw--examples swiper\">\n        <div class=\"swiper-wrapper\">\n                    <picture class=\"swiper-slide overflow-hidden hover--anim -scale-img\">\n            <source media=\"(min-width: 1280px)\" srcset=\"https:\/\/hpbcrti.com\/assets\/uploads\/2024\/09\/long-term-results-of-liver-first-approach-strategy.jpg, https:\/\/hpbcrti.com\/assets\/uploads\/2024\/09\/long-term-results-of-liver-first-approach-strategy.jpg 2x\">\n            <source media=\"(min-width: 1024px)\" srcset=\"https:\/\/hpbcrti.com\/assets\/uploads\/2024\/09\/long-term-results-of-liver-first-approach-strategy-743x417.jpg, https:\/\/hpbcrti.com\/assets\/uploads\/2024\/09\/long-term-results-of-liver-first-approach-strategy.jpg 2x\">\n            <source media=\"(min-width: 768px)\" srcset=\"https:\/\/hpbcrti.com\/assets\/uploads\/2024\/09\/long-term-results-of-liver-first-approach-strategy-768x431.jpg, https:\/\/hpbcrti.com\/assets\/uploads\/2024\/09\/long-term-results-of-liver-first-approach-strategy-768x431.jpg 2x\">\n            <source media=\"(min-width: 360px)\" srcset=\"https:\/\/hpbcrti.com\/assets\/uploads\/2024\/09\/long-term-results-of-liver-first-approach-strategy-386x217.jpg, https:\/\/hpbcrti.com\/assets\/uploads\/2024\/09\/long-term-results-of-liver-first-approach-strategy-768x431.jpg 2x\">\n            <img decoding=\"async\" class=\"w-full h-full\" src=\"https:\/\/hpbcrti.com\/assets\/uploads\/2024\/09\/long-term-results-of-liver-first-approach-strategy-386x217.jpg\" srcset=\"https:\/\/hpbcrti.com\/assets\/uploads\/2024\/09\/long-term-results-of-liver-first-approach-strategy-768x431.jpg 2x\" alt=\"\">\n          <\/picture>\n                <\/div>\n      <\/div>\n    <\/div>\n\n  ","protected":false},"excerpt":{"rendered":"<p>Eric Herrero, Mar\u00eda Galofr\u00e9, Alba Z\u00e1rate, Maribel Garc\u00eda-Domingo, Judith Camps, Fernando Pardo, Francisco Espin y Esteban Cugat. Retrospective descriptive analysis from a prospective database of hepatectomies from liver metastases (LM) from CRC in two centers. Between 2007-2019, 88 patients with CRC-ASLM (advanced synchronous liver metastases) were included in a LFA scheme. Bilobar (LM) was present [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":1317,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"miembro-del-equipo":[50,52,57,64],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Long-term results of liver-first approach strategy in patients with advanced synchronous liver metastases from colorectal cancer. - HPB Can Ruti<\/title>\n<meta name=\"description\" content=\"Colorectal metastasis. Tumor response to neoadjuvant chemotherapy, optimising potentially curative liver resection. Survival assessment.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hpbcrti.com\/en\/article\/liver-first-approach-strategy-in-liver-metastases-from-colorectal-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Long-term results of liver-first approach strategy in patients with advanced synchronous liver metastases from colorectal cancer. - HPB Can Ruti\" \/>\n<meta property=\"og:description\" content=\"Colorectal metastasis. Tumor response to neoadjuvant chemotherapy, optimising potentially curative liver resection. Survival assessment.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hpbcrti.com\/en\/article\/liver-first-approach-strategy-in-liver-metastases-from-colorectal-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"HPB Can Ruti\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-12T13:22:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-20T09:05:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hpbcrti.com\/assets\/uploads\/2024\/09\/long-term-results-of-liver-first-approach-strategy.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1208\" \/>\n\t<meta property=\"og:image:height\" content=\"678\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/hpbcrti.com\/en\/article\/liver-first-approach-strategy-in-liver-metastases-from-colorectal-cancer\/\",\"url\":\"https:\/\/hpbcrti.com\/en\/article\/liver-first-approach-strategy-in-liver-metastases-from-colorectal-cancer\/\",\"name\":\"Long-term results of liver-first approach strategy in patients with advanced synchronous liver metastases from colorectal cancer. - HPB Can Ruti\",\"isPartOf\":{\"@id\":\"https:\/\/www.hpbcrti.com\/en\/#website\"},\"datePublished\":\"2024-09-12T13:22:40+00:00\",\"dateModified\":\"2024-11-20T09:05:21+00:00\",\"author\":{\"@id\":\"https:\/\/www.hpbcrti.com\/en\/#\/schema\/person\/41558e138cadc20216a57c49f1b5d69c\"},\"description\":\"Colorectal metastasis. Tumor response to neoadjuvant chemotherapy, optimising potentially curative liver resection. Survival assessment.\",\"breadcrumb\":{\"@id\":\"https:\/\/hpbcrti.com\/en\/article\/liver-first-approach-strategy-in-liver-metastases-from-colorectal-cancer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/hpbcrti.com\/en\/article\/liver-first-approach-strategy-in-liver-metastases-from-colorectal-cancer\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/hpbcrti.com\/en\/article\/liver-first-approach-strategy-in-liver-metastases-from-colorectal-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/www.hpbcrti.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Long-term results of liver-first approach strategy in patients with advanced synchronous liver metastases from colorectal cancer.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.hpbcrti.com\/en\/#website\",\"url\":\"https:\/\/www.hpbcrti.com\/en\/\",\"name\":\"HPB Can Ruti\",\"description\":\"Grupo especializado y l\u00edder en procedimientos quir\u00fargicos avanzados para tratar enfermedades del h\u00edgado, el p\u00e1ncreas y las v\u00edas biliares\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.hpbcrti.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.hpbcrti.com\/en\/#\/schema\/person\/41558e138cadc20216a57c49f1b5d69c\",\"name\":\"Editor\",\"url\":\"https:\/\/hpbcrti.com\/en\/author\/kom_editor\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Long-term results of liver-first approach strategy in patients with advanced synchronous liver metastases from colorectal cancer. - HPB Can Ruti","description":"Colorectal metastasis. Tumor response to neoadjuvant chemotherapy, optimising potentially curative liver resection. Survival assessment.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hpbcrti.com\/en\/article\/liver-first-approach-strategy-in-liver-metastases-from-colorectal-cancer\/","og_locale":"en_US","og_type":"article","og_title":"Long-term results of liver-first approach strategy in patients with advanced synchronous liver metastases from colorectal cancer. - HPB Can Ruti","og_description":"Colorectal metastasis. Tumor response to neoadjuvant chemotherapy, optimising potentially curative liver resection. Survival assessment.","og_url":"https:\/\/hpbcrti.com\/en\/article\/liver-first-approach-strategy-in-liver-metastases-from-colorectal-cancer\/","og_site_name":"HPB Can Ruti","article_published_time":"2024-09-12T13:22:40+00:00","article_modified_time":"2024-11-20T09:05:21+00:00","og_image":[{"width":1208,"height":678,"url":"https:\/\/www.hpbcrti.com\/assets\/uploads\/2024\/09\/long-term-results-of-liver-first-approach-strategy.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/hpbcrti.com\/en\/article\/liver-first-approach-strategy-in-liver-metastases-from-colorectal-cancer\/","url":"https:\/\/hpbcrti.com\/en\/article\/liver-first-approach-strategy-in-liver-metastases-from-colorectal-cancer\/","name":"Long-term results of liver-first approach strategy in patients with advanced synchronous liver metastases from colorectal cancer. - HPB Can Ruti","isPartOf":{"@id":"https:\/\/www.hpbcrti.com\/en\/#website"},"datePublished":"2024-09-12T13:22:40+00:00","dateModified":"2024-11-20T09:05:21+00:00","author":{"@id":"https:\/\/www.hpbcrti.com\/en\/#\/schema\/person\/41558e138cadc20216a57c49f1b5d69c"},"description":"Colorectal metastasis. Tumor response to neoadjuvant chemotherapy, optimising potentially curative liver resection. Survival assessment.","breadcrumb":{"@id":"https:\/\/hpbcrti.com\/en\/article\/liver-first-approach-strategy-in-liver-metastases-from-colorectal-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hpbcrti.com\/en\/article\/liver-first-approach-strategy-in-liver-metastases-from-colorectal-cancer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/hpbcrti.com\/en\/article\/liver-first-approach-strategy-in-liver-metastases-from-colorectal-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.hpbcrti.com\/en\/"},{"@type":"ListItem","position":2,"name":"Long-term results of liver-first approach strategy in patients with advanced synchronous liver metastases from colorectal cancer."}]},{"@type":"WebSite","@id":"https:\/\/www.hpbcrti.com\/en\/#website","url":"https:\/\/www.hpbcrti.com\/en\/","name":"HPB Can Ruti","description":"Grupo especializado y l\u00edder en procedimientos quir\u00fargicos avanzados para tratar enfermedades del h\u00edgado, el p\u00e1ncreas y las v\u00edas biliares","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hpbcrti.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.hpbcrti.com\/en\/#\/schema\/person\/41558e138cadc20216a57c49f1b5d69c","name":"Editor","url":"https:\/\/hpbcrti.com\/en\/author\/kom_editor\/"}]}},"_links":{"self":[{"href":"https:\/\/hpbcrti.com\/en\/wp-json\/wp\/v2\/posts\/1535"}],"collection":[{"href":"https:\/\/hpbcrti.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hpbcrti.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hpbcrti.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/hpbcrti.com\/en\/wp-json\/wp\/v2\/comments?post=1535"}],"version-history":[{"count":1,"href":"https:\/\/hpbcrti.com\/en\/wp-json\/wp\/v2\/posts\/1535\/revisions"}],"predecessor-version":[{"id":1641,"href":"https:\/\/hpbcrti.com\/en\/wp-json\/wp\/v2\/posts\/1535\/revisions\/1641"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hpbcrti.com\/en\/wp-json\/wp\/v2\/media\/1317"}],"wp:attachment":[{"href":"https:\/\/hpbcrti.com\/en\/wp-json\/wp\/v2\/media?parent=1535"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hpbcrti.com\/en\/wp-json\/wp\/v2\/categories?post=1535"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hpbcrti.com\/en\/wp-json\/wp\/v2\/tags?post=1535"},{"taxonomy":"miembro-del-equipo","embeddable":true,"href":"https:\/\/hpbcrti.com\/en\/wp-json\/wp\/v2\/miembro-del-equipo?post=1535"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}